Press releases
- Interim report January – September 2022
- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2022
- Nomination Committee Appointed for the Annual General Meeting 2023 in Promore Pharma
- Promore Pharma provides an update on the Phase II clinical trial with ensereptide
- Promore Pharma Interim report January – June 2022
Interim report January – September 2022
Promore Pharma AB (publ) published its interim report for the third quarter 2022 on 29 November 2022.
The day after, the 30 November at 11:00 CET, the company will host a webcast telephone conference with President and CEO Jonas Ekblom, with an update for the quarter and upcoming activities. After the presentation there will be a Q&A session. The conference call will be held in Swedish.
